Rocket


Overview
Financials
News + Filings
Key Docs
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
Omthera Pharmaceuticals, Inc. (OMTH) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/29/2013 15-12B Form 15-12B - Securities registration termination [Section 12(b)]
07/23/2013 SC 13D/A NEW ENTERPRISE ASSOCIATES 13 LP has filed a Schedule 13D for Omthera Pharmaceuticals, Inc.
07/22/2013 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/18/2013 8-K Quarterly results
07/18/2013 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
07/18/2013 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
07/16/2013 8-K Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits
Docs: "Omthera Stockholders Approve Acquisition by AstraZeneca"
07/11/2013 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
07/09/2013 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
06/27/2013 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
06/13/2013 DEFM14A Form DEFM14A - Definitive proxy statement relating to merger or acquisition
06/13/2013 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
05/28/2013 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans
05/28/2013 8-K Acquisition/merger/asset purchase announced
Docs: "Agreement and Plan of Merger, among Omthera Pharmaceuticals, Inc., Zeneca, Inc. and KAFA Acquisition Corp",
"Form of Contingent Value Rights Agreement, by and between Zeneca, Inc. and the Rights Agent",
"Stockholder Voting Agreement, by and between Zeneca, Inc. and Gerald L. Wisler",
"Stockholder Voting Agreement, by and between Zeneca, Inc. and Michael H. Davidson",
"Stockholder Voting Agreement, by and among Zeneca, Inc., New Enterprise Associates 13, L.P., and NEA Ventures 2001, Limited Partnership",
"Stockholder Voting Agreement, by and between Zeneca, Inc. and Sofinnova Capital VI FCPR"
05/28/2013 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
05/28/2013 10-Q Quarterly Report for the period ended March 31, 2013
05/28/2013 8-K Quarterly results
Docs: "Omthera Pharmaceuticals Announces First Quarter 2013 Financial Results",
"AstraZeneca to Acquire Omthera Pharmaceuticals Including NDA-Ready Novel Dyslipidemia Treatment to Complement Cardiovascular Portfolio AstraZeneca today announced that it has entered into a definitive agreement to acquire Omthera Pharmaceuticals, a specialty pharmaceutical company based in Princeton, New Jersey, focused on the development and commercialization of new therapies for abnormal levels of lipids in the blood, referred to as dyslipidemia. Omthera's investigational product, EpanovaTM, for the potential treatment of patients with very high triglycerides, is a novel omega-3 free fatty acid composition that has been shown to bolster levels of eicosapentaenoic acid and docosahexaenoic acid significantly in the blood. In studies to date, it has been shown to reduce triglyceride levels ..."
05/28/2013 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
04/26/2013 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
04/23/2013 SC 13D Omthera Pharmaceuticals, Inc. reports a 29.3% stake in Omthera Pharmaceuticals, Inc.
04/23/2013 SC 13D Omthera Pharmaceuticals, Inc. reports a 23.9% stake in Omthera Pharmaceuticals, Inc.
04/12/2013 424B4 Form 424B4 - Prospectus [Rule 424(b)(4)]
04/12/2013 EFFECT Form EFFECT - Notice of Effectiveness
04/10/2013 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
04/01/2013 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933 [Amend]
02/28/2013 D Form D - Notice of Exempt Offering of Securities
03/15/2011 D Form D - Notice of Exempt Offering of Securities
11/27/2009 D Form D - Notice of Exempt Offering of Securities

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy